Hosted on MSN5h
Novel Drug Eases Disease Activity in Dermatomyositis
Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...
Hosted on MSN11h
Mike Flanagan's Dark Tower Series Needs To Explore More of Roland's Parents and their History
Roland's parents, Steven and Gabrielle Deschain, were pivotal figures that shaped him into the hero of The Dark Tower series.
Taiwan News1d
Cell and Gene Therapy Market (CAGR) of 28.2%, Trend weaver’s Tale The Enchantment of Latest Rising Trends Unveiled
Additionally, in the realm of acquired diseases, such as certain cancers and autoimmune conditions, cell and gene therapies offer novel approaches to modulating the immune system and targeting ...
RBC Capital Remains a Buy on Karyopharm Therapeutics (KPTI)
RBC Capital analyst Brian Abrahams maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) on January 7 and set a price ...
BioSpace6d
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell ...
Ulcerative Colitis Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Therapies, Prevalence and Companies by DelveInsight
The key Ulcerative Colitis therapies expected to launch in the market include Jyseleca (filgotinib), Rinvoq (Upadacitinib), ...
Contineum Therapeutics, Inc. Class A (CTNM) Receives a Buy from RBC Capital
RBC Capital analyst Brian Abrahams maintained a Buy rating on Contineum Therapeutics, Inc. Class A (CTNM – Research Report) yesterday and set a ...
FierceBiotech6d
Velia Therapeutics winds down but stays loyal to 'therapeutic potential of microproteins'
Velia Therapeutics has announced it is winding down its operations while staying loyal to the therapeutic potential of ...